wont be adding to my position as none of my 4 requirements have been met 1 a,b, c, or d
After watching the crux interview i hardly know where to start\
1. Capital raising incoming- requirements by a supporting broker- Raise size $20- $30m IMO
(a) demonstrate that the business is cutting costs. This means cutting staff and salaries including the MD's. Not simply moving staff around which is like shuffling the deck chairs on the titanic(
b) Dealing with the outstanding - contingent liability at point 13. in the half yearly ASX announcement 13/3/ 2023(
c) corralling the short sellers to support the raise and cover their positions
(d) board renewal
Comments
2.Looks like no meaningful cash flow until 20263. Chris talking about PE's of 70 is delusional
4. Spodumene discovery talk is wildly premature waiting for the raise to add to my position assuming the points at 1. are largely met
GLTAH
- Forums
- ASX - By Stock
- NMT
- Ann: Neometals Launches Placement and Entitlement Offer
NMT
neometals ltd
Add to My Watchlist
1.37%
!
7.2¢

Ann: Neometals Launches Placement and Entitlement Offer, page-21
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.2¢ |
Change
-0.001(1.37%) |
Mkt cap ! $55.39M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.0¢ | $103.0K | 1.434M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 146786 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 3363 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 146786 | 0.071 |
6 | 312090 | 0.070 |
3 | 86155 | 0.069 |
2 | 154459 | 0.068 |
4 | 171400 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 3363 | 1 |
0.073 | 9087 | 1 |
0.078 | 96516 | 1 |
0.080 | 36036 | 3 |
0.083 | 17000 | 1 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
NMT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online